AzTrials
AzTrials

Postoperative DeliriumNCT07042503

Effects of Different Preoperative Oral Rehydration Protocols in Undergoing Thoracoscopic Radical Lung Cancer Surgery

An observational study of Postoperative Delirium, run by Fujian Medical University Union Hospital.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to compare the new preoperative oral rehydration protocol (administering 50-100 mL of clear fluids or carbohydrate-rich beverages orally every hour until the patient arrives at the operating room) with the traditional preoperative protocol (consuming 200-300 mL of water orally two hours prior to… Read more about this study

Who is it for?
Ages 65 to 80 years
Conditions the study is for
Postoperative Delirium
How many people
420 participants
Where
No sites listed yet
Study dates
1 Jul 2025to 1 Jul 2026
How long will I take part?
4 Days
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 80 years
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: elderly patients undergoing thoracoscopic lung cancer radical surgery

Who may be able to join

  • Elderly patients aged 65 or above who are scheduled to undergo thoracoscopic radical lung cancer surgery.
  • American Society of Anesthesiologists (ASA) classification levels II-III.
  • No severe cognitive impairment (Mini-Mental State Examination (MMSE) score ≥ 24).
  • Able to cooperate with the study and sign the informed consent form.

Who cannot join

  • Combined with severe functional impairments of important organs such as the heart, liver, and kidneys.
  • Suffering from metabolic diseases such as diabetes and hyperthyroidism.
  • Having digestive system diseases such as gastric emptying disorders, dysphagia, and intestinal obstruction.
  • Allergic or intolerant to carbohydrates.
  • Had received treatments such as radiotherapy and chemotherapy before the surgery that might affect the research indicators.
  • Patients with mental disorders or cognitive dysfunction.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Effects of Different Preoperative Oral Rehydration Protocols on Safety, Comfort, and Postoperative Outcomes in Elderly Patients Undergoing Thoracoscopic Radical Lung Cancer Surgery: A Randomized Controlled Trial

This study aims to compare the new preoperative oral rehydration protocol (administering 50-100 mL of clear fluids or carbohydrate-rich beverages orally every hour until the patient arrives at the operating room) with the traditional preoperative protocol (consuming 200-300 mL of water orally two hours prior to surgery). The objective is to investigate the effects of these two protocols on the safety (e.g., risk of reflux and aspiration), comfort (e.g., levels of hunger, thirst, and anxiety), gastric emptying status (as assessed by gastric ultrasound indicators), and postoperative outcomes (e.g., incidence of postoperative delirium, insulin resistance, and inflammatory factor levels) in elderly patients undergoing thoracoscopic lung cancer radical surgery. This research seeks to identify a more appropriate preoperative rehydration protocol for elderly lung cancer patients.

Read the detailed description

This study employed a randomized controlled double-blind trial, including 420 elderly patients (aged 65 and above) who were scheduled to undergo thoracoscopic lung cancer radical surgery. The efficacy of three preoperative oral rehydration regimens was compared. The control group orally consumed 200-300ml of clear water 2 hours before the operation; the intervention group 1 orally consumed 50-100ml of clear water every hour before the operation; the intervention group 2 orally consumed 50-100ml of 12.5% carbohydrate beverages every hour before the operation, all requiring to be consumed slowly within 10-15 minutes. The evaluation indicators included: safety (intraoperative reflux aspiration, postoperative nausea and vomiting, incision and pulmonary infection rates), gastric ultrasound (amount of fluid in the stomach and emptying time), comfort (VAS for assessing hunger and thirst, SAS for assessing anxiety), postoperative delirium (CAM scale combined with electroencephalogram), insulin resistance (FPG, FINS, and HOMA-IR), and inflammatory factors (Interleukin-6, Tumor necrosis factor -α, C-reactive protein). The research data were analyzed using SPSS software to clarify the impact of different rehydration regimens on elderly patients.

Keywords
preoperative oral rehydration protocol, Postoperative delirium, insulin resistance, gastric emptying status, preoperative anxiety
Medical subject headings
Emergence Delirium, Insulin Resistance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07042503
Study groupRoleWhat they receive
Control Arm2-hour Preoperative Ingestion of 200-300 mL clear water
Intervention Arm 1Hourly Preoperative Ingestion of 50-100 mL clear water
Intervention Arm 2Hourly Preoperative Ingestion of 50-100 mL 12.5% carbohydrate-containing beverages

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. postoperative delirium

    The Confusion Assessment Method - Short Form(CAM-S) scoring for postoperative delirium is as follows:

    Total score 20 points, 0-6 points :Mild delirium; 7-12 points:Moderate delirium;

    ≥13 points: Severe delirium.

    Measured: One to three days after the operation

  2. preoperative anxiety

    The Generalized Anxiety Disorder-7 (GAD-7) scale for preoperative anxiety assessment is as follows:Total score: 21 points,0-4 points: Normal,5-9 points: Mild anxiety,10-14 points: Moderate anxiety,≥15 points: Severe anxiety.

    Measured: One day before the operation and in the morning of the operation

  3. The amount of fluid in the stomach

    Ultrasound examination of the cross-sectional area of the antrum of the stomach

    Measured: 2 hours before the operation, 1 hour before the operation, and before anesthesia induction

  4. insulin resistance

    venous blood was collected from the patients to detect fasting plasma glucose (FPG), insulin (FINS), and homeostasis model assessment of insulin resistance index (HOMA-IR).

    Measured: on the early morning of the day before the operation,the first day and the third day after operation

Secondary outcomes (7)
  1. Perioperative hunger

    The Visual Analogue Scale (VAS) allowed patients to rate their feelings of hunger (0-10 points, 0 for no hunger and 10 for extreme hunger) and thirst (0-10 points, 0 for no thirst and 10 for extreme thirst)

    Measured: 2 hours and 1 hour before the operation, before anesthesia induction and 6 hours after the operation

  2. Perioperative thirst

    The Visual Analogue Scale (VAS) was used to score the sensation of thirst (on a scale of 0 to 10, where 0 indicates no sensation of thirst and 10 indicates extreme thirst)

    Measured: 2 hours and 1 hour before the operation, before anesthesia induction and 6 hours after the operation

  3. The incidence of reflux aspiration during the perioperative period

    Closely observe whether the patient has reflux or aspiration

    Measured: During the operation and 3 days after the operation

  4. The incidence of perioperative nausea and vomiting

    Record the frequency and severity of nausea and vomiting

    Measured: During the operation and 3 days after the operation

  5. C-reactive protein

    The fasting venous blood of the patients was collected and detected by immunoturbidimetry.

    Measured: on the early morning of the day before the operation,the first day and the third day after operation

  6. Tumor necrosis factor -α

    The fasting venous blood of the patients was collected and detected by enzyme-linked immunosorbent assay (ELISA).

    Measured: on the early morning of the day before the operation,the first day and the third day after operation

  7. Interleukin-6

    The fasting venous blood of the patients was collected and detected by enzyme-linked immunosorbent assay (ELISA).

    Measured: on the early morning of the day before the operation,the first day and the third day after operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2025
  2. Study start1 Jul 2025 (estimated)
  3. Primary completion1 Jul 2026 (estimated)
  4. Study completion1 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
420 participants (estimated)
Target duration
4 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT07042503
Sponsor's protocol ID
fish77033
Status last verified
Jun 2025
First submitted
16 Jun 2025
Last updated
29 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The way of sharing IPD:ResMan, http://www.medresman.org.cn/login.aspx

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Delirium, run by Fujian Medical University Union Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nan Lin (+8618518134145, 117806006@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

postoperative delirium (time frame: One to three days after the operation). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in